Cargando…

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis

Due to the unpredictable course and heterogenous treatment response in multiple sclerosis (MS), there is a clear need for biomarkers that reflect disease activity in the clinical follow-up of these patients. Neurofilaments are neuron-specific components of the cytoskeleton that can be assayed in dif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varhaug, Kristin N., Torkildsen, Øivind, Myhr, Kjell-Morten, Vedeler, Christian A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460359/ https://www.ncbi.nlm.nih.gov/pubmed/31024432 http://dx.doi.org/10.3389/fneur.2019.00338

Ejemplares similares

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Neurofilament light chain predicts disease activity in relapsing-remitting MS
por: Varhaug, Kristin N., et al.
Publicado: (2017)

Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis
por: Bhan, Alok, et al.
Publicado: (2021)

Safety of breast feeding during rituximab treatment in multiple sclerosis
por: Rød, Brit Ellen, et al.
Publicado: (2023)

Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
por: Depoorter, Antoinette, et al.
Publicado: (2018)

Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis
por: Kouchaki, Ebrahim, et al.
Publicado: (2021)

Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
por: Krajnc, Nik, et al.
Publicado: (2022)

Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study
por: Torgauten, Hilde Marie, et al.
Publicado: (2021)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
por: Ferreira-Atuesta, Carolina, et al.
Publicado: (2021)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
por: Riemer, Frank, et al.
Publicado: (2023)

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
por: Reinert, Marie-Christine, et al.
Publicado: (2020)

Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis
por: Mariottini, Alice, et al.
Publicado: (2022)

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
por: Gil-Perotin, Sara, et al.
Publicado: (2019)

Serum Neurofilament Light Chain Levels May Be a Marker of Lower Motor Neuron Damage in Amyotrophic Lateral Sclerosis
por: Zhang, Linjing, et al.
Publicado: (2022)

CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression
por: Sun, Qionghua, et al.
Publicado: (2020)

Blood neurofilament light chain in Parkinson’s disease
por: Buhmann, Carsten, et al.
Publicado: (2023)

Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple Sclerosis
por: Proschmann, Undine, et al.
Publicado: (2021)

The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

Antibodies to neurofilament light as potential biomarkers in multiple sclerosis
por: Puentes, Fabiola, et al.
Publicado: (2021)

Evidence of polygenic regulation of the physiological presence of neurofilament light chain in human serum
por: Herrera-Rivero, Marisol, et al.
Publicado: (2023)

Serum neurofilament light chain in myasthenia gravis subgroups: An exploratory cohort and case–Control study
por: Stascheit, Frauke, et al.
Publicado: (2023)

Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy
por: Eid, Karine, et al.
Publicado: (2022)

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
por: Lu, Ching-Hua, et al.
Publicado: (2015)

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

Development of a Highly Sensitive Neurofilament Light Chain Assay on an Automated Immunoassay Platform
por: Lee, Stephen, et al.
Publicado: (2022)

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021)

Decreased neurofilament light chain levels in estriol‐treated multiple sclerosis
por: Voskuhl, Rhonda, et al.
Publicado: (2022)

CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration
por: Pawlitzki, Marc, et al.
Publicado: (2018)

Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders
por: Kammeyer, Ryan, et al.
Publicado: (2022)

Serum neurofilament light as a biomarker in progressive multiple sclerosis
por: Kapoor, Raju, et al.
Publicado: (2020)

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
por: Disanto, Giulio, et al.
Publicado: (2017)

CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome—Sign of Inflammation
por: Pawlitzki, Marc, et al.
Publicado: (2018)

Serum glial fibrillary acidic protein and neurofilament light chain in patients with early treated phenylketonuria
por: Lotz-Havla, Amelie S., et al.
Publicado: (2022)

Serum neurofilament light chain levels are associated with early neurological deterioration in minor ischemic stroke
por: Li, Jie, et al.
Publicado: (2023)

No association of tobacco use and disease activity in multiple sclerosis
por: Kvistad, Silje, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_44e6h15p1j0vnmk19khr5rldd2